Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma [Yahoo! Finance]
Tivic Health Systems, Inc. (TIVC)
Company Research
Source: Yahoo! Finance
7 min read In This Article TIVC Broad licensing agreement accelerates Tivic's transformation into a diversified therapeutics company, adds late-stage immunotherapeutic to clinical pipeline. Potential for FDA approval within 24 months. FREMONT, Calif., February 12, 2025 BUSINESS WIRE )--Tivic Health Systems, Inc., (Nasdaq: TIVC) today announced it has acquired worldwide exclusive license rights from Statera Biopharma (OTC: STAB) to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimod™ for the treatment of acute radiation syndrome (ARS). In addition, the company has acquired an exclusive option to license five additional indications and clinical use cases for Entolimod and its derivative, Entalasta™. This broad licensing agreement est
Read more
Impact Snapshot
Event Time:
TIVC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TIVC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TIVC alerts
High impacting Tivic Health Systems, Inc. news events
Weekly update
A roundup of the hottest topics
TIVC
News
- Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous SystemBusiness Wire
- Tivic Health Systems, Inc. Announces Reverse Stock SplitBusiness Wire
- Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus NerveBusiness Wire
- Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team [Yahoo! Finance]Yahoo! Finance
- Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership TeamBusiness Wire
TIVC
Sec Filings
- 3/6/25 - Form 8-K
- 3/5/25 - Form 8-K
- 2/24/25 - Form 4
- TIVC's page on the SEC website